Becton Dickinson
$67.25 B
Share price
Change (1 day)
Change (1 year)

Becton Dickinson, also known as BD, is one of the largest international medical technology companies that develops, produces and sells disposable medical devices, device systems and reagents. BD supplies hospitals, health care facilities, life scientists, clinical laboratories and the pharmaceutical industry.

Revenue for Becton Dickinson (BDX)

Revenue in 2022 (TTM): $19.40 B

According to Becton Dickinson's latest financial reports the company's current revenue (TTM) is $19.40 B. In 2021 the company made a revenue of $19.92 B an increase over the years 2020 revenue that were of $18.20 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Becton Dickinson from 2001 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$19.40 B-2.6%
2021$19.92 B9.45%
2020$18.20 B4.92%
2019$17.35 B1.71%
2018$17.06 B39.28%
2017$12.25 B-1.35%
2016$12.41 B10.71%
2015$11.21 B32.24%
2014$8.48 B3.83%
2013$8.16 B4.21%
2012$7.83 B-0.46%
2011$7.87 B7.91%
2010$7.29 B-1.06%
2009$7.37 B2.67%
2008$7.18 B9.44%
2007$6.56 B10.83%
2006$5.92 B6.89%
2005$5.54 B10.29%
2004$5.02 B7.44%
2003$4.67 B12.95%
2002$4.13 B7.36%
2001$3.85 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$44.16 B 127.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.74 B-24.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.86 B-74.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.62 B-81.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.79 B-85.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.02 B-79.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.11 B-68.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.80 B-85.55%๐Ÿ‡บ๐Ÿ‡ธ USA